How a Cancer Drug Carrier’s Structure Can Help Selectively Target Cancer Cells

Scientists in Japan reveal how optimizing the structure of porphyrin derivatives can help improve drug delivery to cells
Cancer cells can be selectively targeted, using biocompatible delivery systems like porphyrins, but how their structure affects their permeability and accumulation into the cells is now well studied yet | Photo courtesy: kjpargeter on Freepik

--

--

--

Tokyo University of Science (TUS) is one of the most well-known, respected, and the largest science-specialized private research universities in Japan.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

The Science Behind Why You Forget Things So Quickly

Shouleh Nikzad: Sharpening Humanity’s Eyes in Space Exploration and Medical Science

Tick Tock, TIME

Introducing “The Field”: A Project of The People’s Science

Probabilities of the Quantum World (Pt-8)

Prime Editing: 2nd Gen CRISPR?

How much water does it take to make an inch of snow?

Plant Biology: The Kernel of Underestimated Science

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Tokyo University of Science

Tokyo University of Science

Tokyo University of Science (TUS) is one of the most well-known, respected, and the largest science-specialized private research universities in Japan.

More from Medium

To Vaxx or not to Vaxx, that is the question!

“With Self-Discipline Anything is Possible”

Chasing Rabbits: Reason in the Age of Cults

When Your Tits Go A Little Bit Rotten